Crossmark

Position Paper From the Spanish Society of Rheumatology on Biosimilar Drugs

Crossref DOI link: https://doi.org/10.1016/j.reumae.2015.03.012

Published Print: 2015-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Abad Hernández, Miguel Ángel

Andreu, José Luis

Caracuel Ruiz, Miguel Ángel

Belmonte Serrano, Miguel Ángel

Díaz-González, Federico

Moreno Muelas, José Vicente
License Information

Text and Data Mining valid from 2015-09-01
More Information

This article is maintained by: Elsevier

Article Title: Position Paper From the Spanish Society of Rheumatology on Biosimilar Drugs

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2015.03.012

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2015.03.009

Content Type: article

Copyright: Copyright © 2015 Elsevier España, S.L.U. All rights reserved.